Editorial Board

• Hans-Olov Adami, Harvard University, USA
• Jia Chen, Mount Sinai School of Medicine, USA
• Brian Cox, Hugh Adam Cancer Epidemiology Unit, University of Otago, New Zealand
• E. P. Diamandis, Mount Sinai Medical Center, USA
• Lynnette Ferguson, University of Auckland, New Zealand
• John D. Groopman, Johns Hopkins University, USA
• Constantin G. Ioannides, The University of Texas M. D. Anderson Cancer Center, USA
• Lovell A. Jones, University of Texas M. D. Anderson Cancer Center, USA
• F. F. Kadlubar, University of Arkansas, USA
• Lidia Larizza, University of Milan, Italy
• L. A. Liotta, George Mason University, USA
• Roberta Mckean-Cowdin, University of Southern California, USA
• Florence Menegaux, National Institute of Health and Medical Research, France
• Paola Muti, Istituti Fisioterapici Ospitalieri, Italy
• Sen J. Pathak, University of Texas M. D. Anderson Cancer Center, USA
• Nicholas C. Popescu, National Cancer Institute, USA
• Thomas E. Rohan, Yeshiva University, USA
• Nathaniel Rothman, National Cancer Institute, USA
• Nicoletta Sacchi, Roswell Park Cancer Institute, USA
• Siegal Sadetzki, Gertner Institute for Epidemiology and Health Policy Research, Israel
• Annie J. Sasco, Université Bordeaux 2, France
• P. G. Shields, Georgetown University, USA
• Jack A. Taylor, National Institute of Environmental Health Sciences, NIH, USA
• T. L. Vaughan, University of Washington, USA
• P. Vineis, Imperial College L ondon, United Kingdom
• Joseph Wiemels, University of California, San Francisco, USA
• Rufang Yeh, University of California, San Francisco, USA
• Wei Zheng, Vanderbilt University, USA